Back to Trades
Total Value
$0
Filing Date
Sep 4, 2026
2 transactions
Trade Summary
On Sep 2, 2026 through Sep 3, 2026, Robinson Elliott, Insider, reported $0 of Hinge Health, Inc. (HNGE) across 2 transactions. The filing covers Class A Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Hinge Health, Inc.
- Ticker Symbol
- HNGE
- CIK
- 0001673743
Insider Information
- Name
- Robinson Elliott
- Role
- Insider
- Location
- LARCHMONT, NY
Filing Details
- Filing Date
- Sep 4, 2026
- Transaction Date
- Sep 2, 2026
- Accession Number
- 0001193125-26-383894
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Class A Common Stock | — | — | Sale | — |
| Sep 3, 2026 | Class A Common Stock | — | — | Sale | — |
Want live alerts when Robinson Elliott trades again?
Download Insider Trades to track HNGE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)On September 2, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 35,918 and 33,717 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.01. These shares were sold in multiple transactions at prices ranging from $92.72 to $93.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F2)The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
- (F3)On September 3, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 516 and 484 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.64. These shares were sold in multiple transactions at prices ranging from $92.05 to $92.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.